berberine and oxonic acid

berberine has been researched along with oxonic acid in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Chen, J; Huang, Z; Jiang, L; Li, Y; Lin, G; Lin, Z; Liu, Y; Mai, L; Su, Z; Xie, J; Xu, L; Yu, Q1
Chen, J; Gong, S; Li, Y; Lin, Y; Liu, Y; Su, Z; Wu, X; Xie, Q; Yan, F; Zhong, L1

Other Studies

2 other study(ies) available for berberine and oxonic acid

ArticleYear
Berberrubine attenuates potassium oxonate- and hypoxanthine-induced hyperuricemia by regulating urate transporters and JAK2/STAT3 signaling pathway.
    European journal of pharmacology, 2021, Dec-05, Volume: 912

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; Berberine; Blood Urea Nitrogen; Chemical and Drug Induced Liver Injury; Creatinine; Cytokines; Disease Models, Animal; Glucose Transport Proteins, Facilitative; Hyperuricemia; Hypoxanthine; Janus Kinase 2; Kidney Diseases; Male; Mice; Organic Anion Transport Protein 1; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Oxonic Acid; Protective Agents; Signal Transduction; STAT3 Transcription Factor; Uric Acid; Xanthine Oxidase

2021
Oxyberberrubine, a novel liver microsomes-mediated secondary metabolite of berberine, alleviates hyperuricemic nephropathy in mice.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2023, Volume: 108

    Topics: Animals; Berberine; Hyperuricemia; Kidney; Mice; Microsomes, Liver; NLR Family, Pyrin Domain-Containing 3 Protein; Oxonic Acid; RNA, Messenger; Uric Acid; Xanthine Oxidase

2023